MedTrace Logo

Liver Transplantation in Intrahepatic Cholangiocarcinoma

NCT06140134 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2026-03-20

No results posted yet for this study

Summary

The aim of the current study is to determine the potential efficacy of liver transplantation in the form of patients' overall survival (OS) after neoadjuvant systemic therapy in patients with biologically responsive locally advanced non-metastatic intrahepatic cholangiocarcinoma (iCCA) in comparison to patients historically treated with chemotherapy alone.

Conditions

  • Intrahepatic Cholangiocarcinoma
  • Cholangiocarcinoma, Intrahepatic

Interventions

PROCEDURE

Liver Transplant

Whole liver allotransplantation will be performed for patients on the liver transplant waiting list

Sponsors & Collaborators

  • Rutgers, The State University of New Jersey

    lead OTHER

Principal Investigators

  • Keri E Lunsford, MD, PhD · Rutgers University

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-15
Primary Completion
2028-11-30
Completion
2029-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06140134 on ClinicalTrials.gov